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ABSTRAK 
 
Infertiliti bermaksud ketidakupayaan mengandung selepas tempoh satu tahun 
melakukan hubungan kelamin tanpa mengamalkan sebarang langkah pencegahan 
kehamilan.  Terdapat pelbagai jenis rawatan untuk infertiliti ini bermula dari rawatan 
pemakanan ubat Clomiphene Citrate hingga ke rawatan invasif seperti bantuan 
teknologi rawatan pembiakan. Objektif kajian hirisan lintang ini adalah untuk 
mengkaji faktor yang terbabit dalam menentukan kejayaan seseorang wanita yang 
mengambil rawatan infertiliti di Hospital Raja Perempuan Zainab II. Seramai 117 
wanita yang terlibat dalam kajian ini dengan menggunakan kaedah persampelan 
keseluruhan populasi. Rekod rawatan pesakit dilihat dan data diambil menggunakan 
proforma yang mengandungi maklumat tentang latarbelakang pesakit, (umur, bangsa, 
tahap pembelajaran, status pekerjaan), maklumat wanita (yang merangkumi 
maklumat tentang haid, masalah infertiliti, hubungan kelamin, sejarah kesihatan dan 
pembedahan dan siasatan tentang penyebab infertiliti), maklumat suami (yang 
merangkumi sejarah ketidaksuburan, sejarah kesihatan dan pembedahan, analisa 
ujian air mani), rawatan bagi infertiliti yang diambil dan pencapaian (berjaya atau 
gagal). Kejayaan pencapaian dibahagikan kepada kehamilan (samada di dalam rahim 
atau di luar rahim) dan keguguran. Kehamilan di dalam rahim dilihat dari sudut 
kaedah bersalin (kelahiran secara normal atau pembedahan), bilangan bayi yang lahir 
(samada seorang atau lebih). Kaedah deskriptif dan regresi logistic berganda telah 
digunakan untuk menjawab objektif dan hipotesis kajian ini. Secara keseluruhannya, 
kadar kejayaan rawatan adalah 20.5% (95% CI:16.8%, 24.2% ) yang menghasilkan 
tiga belas kandungan di dalam rahim, sepuluh keguguran dan satu kandungan di luar 
rahim. Kesemua kandungan di dalam rahim  menghasilkan seorang bayi, tiada kes 
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kembar yang dicatatkan. Dua daripada bayi yang lahir adalah pramatang dan 
selebihnya lahir genap tempoh matang. Tujuh kehamilan di dalam rahim ini melalui 
proses bersalin normal (SVD) dan enam melalui proses pembedahan (LSCS) bagi 
tujuan kehamilan unggul (dua kes), bayi lemas (2 kes) dan satu kes kedudukan uri 
dibawah (placenta praevia). Analisis regresi logistic berganda menunjukkan umur 
wanita semasa haid kali pertama    (adj OR= 1.59,95% CI: 1.05, 2.42, p-value= 
0.030)   mempunyai kaitan yang signifikan apabila dibandingkan dengan umur 
wanita dan suami, jisim berat badan (BMI), tempoh percubaan untuk hamil, tabiat 
merokok, karakter air mani dan rawatan yang diambil. Pecahan wanita yang berjaya 
selepas rawatan secara keseluruhannya memuaskan dan kebolehan untuk berjaya 
selepas rawatan infertiliti ini lebih cenderung kepada wanita yang mengalami haid 
yang pertama di umur yang lewat. 
 
Kata kunci: infertiliti, kehamilan di dalam rahim, kehamilan di luar rahim, 
keguguran, umur semasa haid pertama kali 
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ABSTRACT 
 
Infertility is defined as the inability to conceive after a year of regular 
unprotected intercourse. Different treatment modalities are available to treat 
infertility ranging from simple, non-invasive oral agent such as clomiphene citrate to 
invasive procedure such as assisted reproductive technology (ART). The objective of 
this cross-sectional study was to determine the factors associated with the successful 
outcome of infertility treatment at Hospital Raja Perempuan Zainab II. Out of 429 
cases, only 117 cases that fulfilled the inclusion creiteria were included. A 
retrospective record review was done using a checklist proforma consisting of 
sociodemography (age, ethnicity, education level and employment status), female 
variables (menstrual history, infertility history, sexual history, medical and surgical 
history, investigations, causes and treatment), male variables (smoking status, 
medical and surgical history, seminal fluid analysis, the last treatment method and its 
outcome ( success or failure). The successful outcome of treatment was categorised 
into intrauterine pregnancy, abortion or extrauterine pregnancy. The end outcome for 
intrauterine pregnancy was assessed in terms of mode of delivery (SVD or LSCS) 
and the fetal outcome (singleton or multiple births and gestational age). The 
descriptive methods and multiple logistic regression were applied to answer the 
objectives and hypotheses of this study. The overall successful rate post infertility 
treatment was 20.5% (95% CI: 16.8%, 24.2%) which resulted in thirteen intrauterine 
pregnancies, ten abortions and one extrauterine pregnancy. All thirteen pregnancies 
resulted in singleton babies, seven were delivered via SVD and six delivered via 
LSCS for precious pregnancy (two cases), fetal distress (2 cases) and one case of 
placenta praevia.  Two of the babies were prematured, and the rest were delivered at 
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term. Analysis from logistic regression showed that age of menarche (adj OR= 
1.59,95% CI: 1.05, 2.42, p-value= 0.030) was the only significant factor affecting the 
successful outcome of infertility treatment  when adjusted for age of men and 
women, BMI, duration of infertility, smoking, sperm characteristics (sperm count, 
percentage of progressive motility and normal morphology) and treatment options. 
The proportion of women with successful outcome post infertility treatment was 
almost similar to other studies and the odds of having a successful outcome are much 
higher in women with late age of menarche. 
 
Keywords: Infertility, intrauterine pregnancy, extrauterine pregnancy, abortion, age 
of menarche. 
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CHAPTER ONE: INTRODUCTION 
1.1 Overview 
 Infertility can be defined by clinical, epidemiological and demographic 
definition. By clinical definition, infertility is customarily defined as the inability to 
conceive after 1 year of regular unprotected intercourse (Zegers-Hochschild et al. 
(2009). The infertility evaluation is typically initiated after 1 year of trying to 
conceive, but in couples with advanced female age (≥ 35 years), most practitioners 
initiate diagnostic evaluation after an inability to conceive for 6 months (Quaas and 
Dokras, 2008). 
 The epidemiologist on the other hand defines infertility as women of 
reproductive age (15-49 years) at risk of becoming pregnant (not pregnant, sexually 
active, not using contraception and not lactating) who report trying unsuccessfully 
for a pregnancy for 2 years or more (Gnoth et al., 2005). This definition is mainly 
used for monitoring and surveillance in epidemiology. 
 Both of these definitions however, are not appropriate when making 
population-based estimates of infertility using household surveys. Clinical definitions 
are designed for early detection and treatment of infertility (Zegers-Hochschild et al., 
2009). A definition and assessment of infertility based on medical histories and 
diagnostic tests is appropriate for clinical settings, where the aim is to understand 
causes and provide treatment as soon as it is indicated. However, measuring patterns 
and trends in infertility at the population level necessitates a measure that may be 
elicited using a standard set of survey questions (Larsen, 2005). The World Health 
Organisation (WHO) epidemiologic definition is more closely aligned with clinical 
practice than demographic definitions are, and may be measured using survey data. 
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However, few household surveys determine whether a couple is trying to become 
pregnant, and the majority do not collect information on past pregnancies, only on 
previous live births (Mascarenhas et al., 2012b). 
 In terms of demographic definitions of infertility, infertility is defined as  an 
inability of those of reproductive age (15-49 years) to become or remain pregnant 
within 5 years of exposure to pregnancy (Rutstein and Shah, 2004). This definition is 
consistent with definition given by Mascarenhas et al., 2012 as an inability to 
become pregnant with a live birth, within 5 years of  exposure based upon a 
consistent union status, lack of contraceptive use, non-lactating and maintaining a 
desire for a child (Mascarenhas et al., 2012b). The 5-year time frame was used as the 
exposure period which is needed to accommodate the time it takes to become 
pregnant and give birth and helps prevent unreported temporary separations, periods 
of post-partum sexual abstinence or lactational amenorrhoea from unduly affecting 
the infertility measure (Mascarenhas et al., 2012).  The preferred outcome is birth 
rather than pregnancies as information on live births is collected more often and 
reported more accurately than pregnancies in the household survey.  
 A common definition of infertility is very important for the appropriate 
management of infertility(Gnoth et al., 2005) as a balanced management of reduced 
fertility requires appropriate timing of infertility investigations and appropriate 
timing of starting treatment to avoid both over- and under-treatment (Brosens et al., 
2004). As a consequence of that, WHO and the International Committee for 
Monitoring Assisted Reproductive Technology (WHO-ICMART) has come to an 
agreement to standardise the definition of infertility based on the clinical definition 
to harmonize international data collection, and to assist in monitoring the availability, 
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efficacy, and safety of assisted reproductive technology (ART) being practiced 
worldwide (Zegers-Hochschild et al., 2009) 
Despite the great success in improving maternal and child health globally in 
the past decade, the focus on infertility has been neglected (Cousens et al., 2011; 
Cui, 2010; Kassebaum et al., 2014). One of the United Nation’s Millennium 
Development Goals was for universal access to reproductive health care by 2015, 
and WHO has recommended that infertility be considered a global health problem as 
the inability to have children can affect both men and women across the globe 
(Hammarberg and Kirkman, 2013). Infertility can lead to distress and depression, as 
well as discrimination and ostracism (Cui, 2010; Sembuya, 2010). The main 
challenges in generating global estimates of infertility are the scarcity of population-
based studies and the inconsistent definitions used in the few high-quality studies 
available (Gurunath et al., 2011). An accurate profile of the prevalence, distribution, 
and trends of infertility is an important first step towards shaping evidence-based 
interventions and policies to reduce the burden of this neglected disability globally 
(Mascarenhas et al., 2012b). 
 A WHO evaluation of Demographic and Health Surveys (DHS) data (2004), 
estimated that about one in every four couples is affected by infertility in developing 
countries (Rutstein and Shah, 2004). Then, in 2010, another WHO study estimated 
48.5 million couples worldwide were infertile (Mascarenhas et al., 2012). Data for 
this study were obtained from DHS, Reproductive Health Surveys, the World 
Fertility Survey, the Pan Arab Project for Family Health and Pan Arab Project for 
Child Development, the European Multicenter Study on Infertility and Subfecundity, 
the Fertility and Family Survey, the United States National Survey of Family Growth 
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and the China In-Depth Fertility Sample Surveys, involving a total of 190 countries 
and territories. The result showed that the prevalence of infertility was highest in 
South Asia, Sub- Saharan Africa, North Africa/Middle East, and Central/Eastern 
Europe and Central Asia. Apart from declines in primary and secondary infertility in 
Sub-Saharan Africa and primary infertility in South Asia, the levels of infertility in 
2010 were similar to those in 1990 in most world regions. However, due to 
population growth, the absolute number of couples affected by infertility had 
increased from 42.0 million in 1990 to 48.5 million in 2010 (Mascarenhas et al., 
2012b).  
 The United Nation World Fertility Data 2012 provides a comparable and up-
to-date set of national data on fertility and the timing of childbearing for all 223 
countries and areas of the world including Malaysia. Among the key indicators used 
are age-specific fertility rates, total fertility and mean age at childbearing and 
children ever born. For each of these indicators and to the extent that data are 
available, data are presented for five reference dates: 1970, 1985, 1995, 2005 and the 
most recent data available. Major sources of data on fertility and the timing of 
childbearing presented in World Fertility Data 2012 are civil registration systems, 
sample surveys and censuses. Total Fertility Rate (TFR) is defined as the average 
number of children a hypothetical cohort of women would have at the end of their 
reproductive period if they were subject during their whole lives to the fertility rates 
of a given period and if they were not subject to mortality. TFR is expressed as 
children per woman. According to the World Fertility Data 2012, Malaysia had a 
total fertility rate of 2.07 within 2005to 2010, a decreasing trend from 6.23 in 1950 to 
1955. This is similar to data from Family Health Development Division, Ministry of 
Health which stated that the TFR in Malaysia latest in 2012 was 2.1 (Dr Majdah 
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Mohamed of Family Health Development Division, Ministry of Health, personal 
communication, 17 December 2014).  
 
1.2 Types of infertility 
Infertility is regarded as a disability which falls under the Convention on the 
Rights of Persons with Disability. Infertility was ranked the 5th highest serious global 
disability (Shakespeare and Officer, 2011).  The disability can be categorized into 
primary infertility and secondary infertility. Primary infertility is defined as the 
absence of a live birth for women who desire for a child and have been in a union for 
at least five years, during which they have not used any contraceptives. When a 
woman is unable to ever bear a child, either due to the inability to become pregnant 
or the inability to carry a pregnancy to a live birth, she would be classified as having 
primary infertility (Mascarenhas et al., 2012).    The prevalence of primary infertility 
is calculated as the number of women in an infertile union divided by the number of 
women in both infertile and fertile unions (Mascarenhas et al., 2012a). 
Primary infertility prevalence among child-seeking women varied by region 
in 2010 from 1.5% in the Latin America/Caribbean region, to 2.6% in the North 
Africa/Middle East region. The decline in primary infertility was greatest in Sub-
Saharan Africa, which experienced a substantial decline in primary infertility, from 
2.7% in 1990 to 1.9%  in 2010, a decline of 0.8 percentage points over the 20-y 
period. The lowest estimated prevalence of primary infertility occurred in middle-
income countries in Latin America (Peru, Bolivia, Ecuador, and El Salvador ) and in 
Poland, Kenya, and the Republic of Korea (0.9%–1.0%). At the other extreme, 13 
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countries in Eastern Europe, North Africa/Middle East, Oceania, and Sub-Saharan 
Africa had prevalence of 3.0% or greater. 
Secondary infertility is defined as the absence of a live birth for women who 
desire a child and have been in a union for at least five years since their last live 
birth, during which they did not use any contraceptives (Mascarenhas et al., 2012a). 
Those who repeatedly spontaneously miscarry or whose pregnancy results in a 
stillbirth, or following a  previous pregnancy or a previous  ability to do so, are then 
not able to carry a pregnancy to a live birth would present with secondary infertile 
(Mascarenhas et al., 2012).  The prevalence of secondary infertility is calculated as 
the number of women in an infertile union divided by the combined number of 
women in infertile and fertile unions. Women in a fertile union have successfully had 
at least one live birth in the past five years and, at the time of the survey, have been 
in a union for at least five years following their first birth (Mascarenhas et al., 
2012a).  
Global and country patterns of secondary infertility were similar to those of 
primary infertility, with two notable exceptions: first, the prevalence of primary 
infertility was high in some countries in the North Africa/Middle East region, notably 
Morocco and Yemen, with prevalence’s greater than 3%, but prevalence of 
secondary infertility was low in those same countries. Second, the prevalence of 
primary infertility observed in the Central/Eastern Europe and Central Asia region 
was low to-intermediate relative to that of other regions, though this region had the 
highest prevalence of secondary infertility. The prevalence of secondary infertility 
ranged from 7.2% in the High Income region and 7.2%  in the North Africa/Middle 
East region to 18.0% in the Central/Eastern Europe and Central Asia region. Most 
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regions experienced non-significant increases in the prevalence of secondary 
infertility between 1990 and 2010 with the exception of Sub-Saharan Africa, where 
the prevalence of secondary infertility declined from 13.5% in 1990 to 11.6 in 2010. 
Like primary infertility, the prevalence of secondary infertility varied by country 
within each region, particularly in Sub-Saharan Africa. 
 
1.3  Causes of infertility 
Infertility has a wide range of causes stemming from three general sources: 
physiological dysfunctions, preventable causes, and unexplained issues. Anatomical, 
genetic, endocrinological  and immunological problems can all cause or contribute to 
infertility(Evens, 2004). Physiological causes of female infertility include: tubal 
blockage, abnormal ovulation, congenital malformation, and endometriosis.  Male 
factors include issues with sperm counts, motility, and quality; and ejaculatory 
dysfunctions. 
 Most primary and secondary infertility in developing countries is attributable 
to infectious disease and subsequent damage or blockage of the fallopian tubes 
(Evens, 2004). Tubal blockage is responsible for up to two-thirds of infertility in 
nulliparous women in sub-Saharan Africa, up to one-third of the infertility in other 
parts of the developing world and up to one-quarter in the developed world.  
Infection-related infertility can be caused by undiagnosed or poorly treated genital 
tract infections, sexually transmitted infections (STIs), or postpartum or post abortion 
infection. Infectious and parasitic diseases such as pelvic tuberculosis, 
schistosomiasis or malaria can also cause infertility. Infertility can be resulted from 
genital scarification or cutting as well. 
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 The most common preventable causes of infertility are sexually transmitted 
infections, especially chlamydia and gonorrhoea(Hull et al., 1985) . Undiagnosed or 
inadequately treated chlamydia and gonorrhea in women can lead to pelvic 
inflammatory disease (PID) which can lead to infertility (Zuky et al., 2005). In men, 
chronic chlamydial genital infection can also possibly lead to infertility (Hull et al., 
1985). A prospective study in Universiti Sains Malaysia Hospital between 2002 and 
2003 found that, among 150 infertile women, six of them had Chlamydial infection 
(Zuky et al., 2005). The prevalence of Chlamydial infection worldwide varies 
depending on the sample of women. But the prevalence rate of 4 % at HUSM at that 
time was almost similar to the prevalence of Chlamydial infection in the United 
Kingdom.  
 The term unexplained infertility usually refers to a diagnosis (or lack of 
diagnosis) made in couples in whom all the standard investigations such as tests of 
ovulation, tubal patency and semen analysis are normal. Unexplained infertility is a 
term that has been applied to as many as 30–40% of infertile couples(Ray et al., 
2012). Unexplained infertility may arise in two ways. Some couples may have some 
subtle, undetected defect in the reproductive process, while in others conception is 
delayed by chance alone, as the couples fecundity may be on the lower side of the 
normal distribution. The later cause may provide a better  prognosis for spontaneous 
pregnancy in such couples than in those with diagnosed causes of infertility (Quaas 
and Dokras, 2008).  
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1.4  Treatment modalities  
 There are different treatment modalities available in treating infertility 
according to the underlying cause. Comparison between centers can be very 
unreliable because of marked variation in the definitive criteria employed. For the 
purpose of this study, the treatment regime discussed in this study will be based on 
the treatment modalities available at Hospital Raja Perempuan Zainab II include  
i. Superovulation with clomiphene citrate (clomid) and natural coitus, without 
intrauterine insemination (IUI) 
ii. Superovulation with clomid or Controlled Ovarian Hyperstimulation (COH) 
with recombinant follicular stimulating hormone( rFSH)  or GnRH and IUI 
iii. Assisted Reproductive Technology (ART) 
 
Clomiphene Citrate (CC) 
Clomiphene Citrate (CC) is a selective oestrogen receptor modulator with 
both oestrogenic and antioestrogenic properties. It was first approved for use in 
women with anovulation in 1967, and has been used as a first-line ovulation 
induction agent for over 40 years (Pritts, 2010). Acting as an antioestrogen, CC 
competitively inhibits the binding of estradiol to its receptors in the hypothalamus 
and pituitary, which in turn blocks the negative feedback effect of endogenous 
oestrogens, including estradiol. This results in an increased secretion of pulsatile 
gonadotrophin-releasing hormone (GnRH) from the hypothalamus, leading to an 
increase in follicle-stimulating hormone (FSH) and luteinising hormone (LH) 
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production and secretion from the pituitary gland. This increase in FSH secretion 
stimulates follicular growth and estradiol production, thereby inducing a mid-cycle 
LH surge and subsequent ovulation. 
Studies with CC have shown an ovulation rate of 60– 85% and a pregnancy 
rate of 30–50% after six ovulatory cycles (Kousta et al., 1997).  This apparent 
discrepancy between good ovulation rates and lower pregnancy rates has been 
attributed to the anti-oestrogenic effects of CC on the endometrium and cervical 
mucus (Hart and Norman, 2006).  
Adverse effects of CC include higher twin and triplet pregnancies, at 5–7% 
and 0.3%, respectively. The incidence of OHSS is also increased but is less than 1%. 
It has also been recommended that the lifetime CC exposure of a patient might place 
the patient at increased risk of ovarian tumours (Cetin et al., 2008). 
 
Intrauterine Insemination (IUI)  
IUI is often suggested to infertile couples in which the woman has at least 
one permeable fallopian tube and the man has partially modified sperm or low sperm 
quality (Merviel et al., 2010). Other indications for IUI include unexplained 
infertility factors, cervical factors, ovulatory dysfunction and endometriosis.   
The advantage of this approach is that some of the associated with IVF are 
avoided, particularly those relating to oocyte retrieval.  There is however significant 
risk of ovarian hyperstimulation syndrome (OHSS), multiple pregnancy and a small 
but finite risk of infection following IUI. 
11 
 
The pregnancy rate depends on sperm parameters, female factors, and the 
ovarian stimulation methods (Merviel et al., 2010). The overall successful pregnancy 
rate of IUI varies from as low as 5% to as high as 70% (Badawy et al., 2009). 
Thereby IUI treatment seems to be far more efficient than natural cycle, clomiphene 
medication and timed intercourse (Bungum et al., 2004). 
 
Assisted Reproductive Technology (ART) 
Many couples, however, fail to conceive after three IUI treatment cycles and 
more advanced fertility treatment (ART) may subsequently be employed (Bungum et 
al., 2004). Based on WHO-ICMART, assisted reproductive technology (ART) means 
all treatments or procedures that include the in vitro handling of both human oocytes 
and sperm or of embryos for the purpose of establishing a pregnancy (Zegers-
Hochschild et al., 2009). This includes, but is not limited to, in vitro fertilization and 
embryo transfer, gamete intrafallopian transfer, zygote intrafallopian transfer, tubal 
embryo transfer, gamete and embryo cryopreservation, oocyte and embryo donation, 
and gestational surrogacy. ART does not include assisted insemination (artificial 
insemination) using sperm from either a woman’s partner or a sperm donor (Zegers-
Hochschild et al., 2009). 
The indications for IVF have expanded to include infertility caused by severe 
male factor, diminished ovarian reserve, ovulatory dysfunction, severe 
endometriosis, and infertility of unexplained cause (Huang and Rosenwaks, 2012). 
This technique also provides a new means of preconception genetic diagnosis and 
preservation of fertility. And in fact, IVF is the most effective treatment option for 
couples with multi-factorial infertility problems (Huang and Rosenwaks, 2012). 
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The increased risk of adverse pregnancy outcomes after ART is a concern as 
ART is associated with multiple pregnancies in more than 30% of ART pregnancies, 
small for gestational age infant and preterm delivery  as well as high maternal 
complications such as preeclampsia, gestational diabetes, placenta praevia, placental 
abruption and caesarean delivery.   
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1.5  Treatment at Hospital Raja Perempuan Zainab II (HRPZ II) 
 
The Infertility Clinic service at Hospital Raja Perempuan Zainab II is a 
subdomain of the Obstetrics and Gynaecology Department which is located at the 
Ambulatory Care Centre (ACC) building since early this year. The Infertility Clinic 
has been in operation since 2005 by a Consultant Obstetrics and Gynaecologist. This 
clinic caters for subfertile and infertile women around Kota Bharu and acts as a 
tertiary clinic that received referral from the whole Kelantan, Hulu Terengganu and 
Kuala Lipis for further management of infertility. As these patients were already seen 
by a medical officer or a specialist prior to visit at Infertility Clinic, HRPZ II, initial 
investigations were already conducted there and patients usually presented to the 
Infertility Clinic with a baseline result. The baseline investigations are day 2 FSH, 
day 21 serum progesterone, LH, thyroid function test.  The investigation result will 
be reviewed by the requested doctor prior to referring patient to the Infertility Clinic. 
Any incomplete investigation or doubtful result usually will be repeated upon visit at 
the Infertility Clinic, HRPZ II including seminal fluid analysis. A transabdominal or 
transvaginal ultrasound scan is also done on the first visit to the Infertility Clinic. 
All female patients were treated with ovarian stimulation agents initially 
using clomiphene citrate (CC) alone, prescribed  at 100 to 150 mg of clomiphene 
citrate starting on day 2 to 6 of the cycle whether or not the investigation result was 
ready.  This method of superovulation must coincide with timed coitus.  The women 
will be followed up again at the Infertility Clinic after one month and will be 
subjected for a trans-vaginal scan and reviewed by a doctor on the next visit.  If there 
is an evidence of pregnancy on scan, the patient will be seen twice before transferred 
to the antenatal care clinic.  
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The clomiphene citrate is usually given for 2-3 cycles and during this time, a 
hysterosalpingogram will be arranged to further investigate the causes of infertility. 
At this point, patient will be counselled for intrauterine insemination (IUI) either  by 
using clomiphene citrate alone and IUI or in combination of clomiphene citrate and 
gonadotrophin(Gonal- For Puregon) and IUI. A serial transvaginal scan (TVS) was 
performed to monitor the growth of thefollicles starting at Day 12 of cycle. Human 
chorionic gonadotrophin (HCG) was administered to the patient when the size of the 
follicles reached ≥18 mm.  
All semen samples from male patients were collected either by masturbation 
following an abstinence period of 3-4 days and left to liquefy for less than 1 hour. 
The samples were assessed according to WHO (2010) criteria. The sperm count 
before wash were divided into two groups: < 100 million per ml and ≥ 100 million 
per ml. Puresperm media was used for sperm preparation. In the gradient method, 
45% and 90% solutions were prepared and then top layered with the semen samples. 
The samples were than centrifuged at 1200rpm for 20 minutes, the pellet was left to 
sink at the bottom and the supernatant discarded. The pellet was then washed with 
2ml of media wash and centrifuged again at 2000rpm for 10 minutes. For 
oligospermia samples, the mini gradient method was used with the same techniques. 
The final pellet was re-suspended with 0.3ml IVF medium. 
The uterine insemination was performed 36-40 hours post HCG injection. 
The procedure  was carried out using a soft IUI catheter (Laboratoire CCD / Gynetics 
Medical Products/ Select Medical Systems/ Cook K-Jets) with the patient in the 
dorsal position. Sterility of the procedure was strictly observed. The catheter was 
gently passed through the cervical canal and the sperm suspension expelled into the 
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uterine cavity. Insemination volumes ranged from 0.5 to 2 ml. The women remained 
supine for 15 min after IUI.  All patients were given Duphaston given for 1 month. 
Three weeks after the IUI procedure, if patients remained amenorrhoeic, urine 
pregnancy test was done and if it was positive, transvaginal ultrasound scan was 
performed a week later to observe for the gestational sac. 
 Patients who were warranted for assisted reproductive treatment (ART) will 
be referred to Hospital Sultanah Nur Zahirah (HSNZ) , Kuala Terengganu as the 
service was not available at HRPZ II. 
 Any women who were found to be pregnant by urine pregnancy test and 
confirmed by unltrasound scan will undergo antenatal follow-up at the Antenatal 
Clinic,another subdomain of the Department of Obstetrics and Gynaecology, HRPZ 
II. Patient will be closely monitored until delivery. The method and place of delivery 
were planned beforehand.     
Despite the various forms of treatment available nowadays, studies done 
previously had looked into the factors associate with the success of specific treatment 
such as intrauterine insemination and assisted reproductive technology. Many factors 
have been reported as influencing pregnancy rates after IUI include the woman’s age, 
the length of infertility, type of infertility, the sperm count analysis, the number of 
mature follicles, the E2 concentration on the day of HCG administration and type of 
catheter used(Merviel et al., 2010) .  Whereas, the key factors affecting success of 
IVF treatment include selection of the appropriate controlled ovarian 
hyperstimulation protocol and gonadotropin dosage, close monitoring of follicular 
growth and serum E2 levels, adjustment of gonadotropin dosage to avoid hyper-
response, and individualised timing of hCG injection(Huang and Rosenwaks, 2012). 
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There is a lack of study done to look at the common factors influencing the success 
in all infertility treatment modalities of which this study is intended to do. 
 
1.6  Rationale of Study 
 Infertility is a public health concern. By looking into the factors which may 
affect the fertility status and its treatment outcome, it is hoped that by doing this 
study, preventive measures including tackling the modifiable factors that may affect 
the outcome of infertility can be done at an earlier stage. The population is growing 
over time, and hence the issues of infertility should be made known to the public and 
to encourage them to seek help and treatment without delaying any further.  
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CHAPTER 2: LITERATURE REVIEW 
2.1  Age  
 
One of the major predictors for a successful infertility treatment was female 
age (Azantee et al., 2011; Merviel et al., 2010). Female age is the single most 
important determinant of spontaneous as well as treatment-related conception, with a 
gradual decline in fertility especially after the age of 35 years (Menkenet al., 1986; 
Templeton et al., 1996). Age related fertility problems increase after 35 and 
dramatically after 40. This could be due to women having had more opportunity to 
acquire pelvic infections or develop endometriosis or premature menopause. 
Demographic studies have shown that more women are delaying childbearing 
at the present time than previously (Botting Dunnell, 2003). The mean age at first 
birth and mean age at childbearing was noted to have increased in all developed 
countries since the 1990s (Evers, 2002; Rutstein and Shah, 2004). As women delay 
childbearing in favour of pursuing education and vocation opportunities, they face 
potentially increased difficulty in becoming pregnant (Evens, 2004). Increasing age 
at childbearing could also increase the prevalence of infertility, as the ability to 
become pregnant and deliver a live birth reduces with age in all populations. This 
trend is expected to cause a corresponding rise in the mean age at which women first 
present with infertility. Similar trend also happened in low- and middle-income 
countries, although first birth still occurs at young ages, the age at first birth has 
increased. As Demographic and Health Surverys (DHS) survey done in the 1990s 
and another survey during 2000–2011 in 40 countries, it was revealed that the overall 
median of the median age at first birth among women aged 25–49 years increased 
from 19.8 to 20.3 years old (Rutstein and Shah, 2004). While the age at first birth has 
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increased, the average number of children has decreased, and thus, the mean age at 
childbearing has not changed in these countries.  
Though the female age is an important predictor for the success of infertility 
treatment, age also plays a role in men. As men age, they are progressively at greater 
risk for orchitis; testicular trauma, torsion, and cancer; varicocele; genital 
inflammation; hormonal changes; systemic diseases, and conditions necessitating 
surgery, all of which can dramatically reduce male fertility (Petraglia et al., 2013). 
High levels of gonadotropins associated with low levels of testosterone (T) indicate 
hypergonadotropic hypogonadism, a state of primary hypogonadism. On the other 
hand, low or normal levels of gonadotropins associated with low T levels tend to 
indicate hypogonadotropic hypogonadism, a state of hypogonadism secondary to a 
dysfunction of hypothalamic and pituitary origin. Varicocele is an abnormal dilation 
of the veins of the plexus pampiniform and is present in 15% of the male population 
and approximately 40% of infertile men. A detrimental effect of varicocele on 
spermatogenesis is found in some men but not all. With age, fertility is reduced in 
men but not as much as in women. For men younger than 35 years, there is no effect, 
but starting in the late 30s, the impact of male age becomes pronounced.  
Although descriptive studies show declines in fertility with age, this can be 
attributed by the less frequent sexual intercourse in older couples. In particular, 
among 35-year-old women, the proportion of many infertile couples will conceive 
naturally in the second year of trying ranges from 43% to 63% depending on age. 
However, result from Dunson et al. (2004) study on the frequency of sexual 
intercourse revealed differently. Increasing frequency of sexual intercourse from 2 to 
3 times per week had relatively little effect on the number of menstrual cycles 
19 
 
required to conceive. However, time to pregnancy increased substantially for couples 
having intercourse only once per week. This probably occurs because the fertile 
interval each menstrual cycle is 5–6 days, so couples having sexual intercourse only 
once a week can miss it completely. It was concluded that women aged 30–34 years 
were similar to the 27 to 29-year-olds, but women aged 35–40 years had further 
reductions in their probabilities of pregnancy (Dunson et al., 2004).   
A study done by (Maheshwari et al., 2008) looking into diagnostic profile 
comparing the older age group of women to the younger age group from a 
population-based data of 7172 women revealed that there was a reduction in the 
diagnosis of ovulatory dysfunction by one-third, but a two-fold rise in unexplained 
and tubal infertility beyond the age of 35 years. Although, the differences are more 
marked at the age of over 35 years, the increase in incidence of unexplained and 
tubal factor infertility is evident from the age of 30 years onwards, as is decreased 
incidence of ovulatory dysfunction.  With the declining numbers and quality of 
oocytes, the female fertility begins to decline sharply around the age of 35 of which 
the cut-off point for advanced maternal age was taken (Cooke et al., 2012). Thus, 
these women over 35 years of age have the priority and should be referred early from 
primary care for investigations and prompt treatment of infertility (Maheshwari et 
al., 2008). 
 Given the relationship between advanced maternal age and the decline in 
fertility, it is not surprising that age is the most important determining factor of 
success in women undergoing in-vitro fertilisation (Templeton et al., 1996). 
Although ART may overcome infertility in younger women, it does not reverse the 
age-dependent decline in fertility. Advanced maternal age is associated with a 
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decline in the number of oocytes retrieved, embryos available for transfer, and 
embryo quality, ultimately resulting in lower implantation, pregnancy, and live birth 
rates. A strong correlation also exists between advanced maternal age and the 
incidence of chromosomal anomalies. The risk of miscarriage approaches 50% 
among women over the age of 40 years. 
  
2.2  Duration of infertility 
 
A higher proportion of women in the older group had increased duration of 
infertility, which would be explained by the fact that women in this population with 
secondary infertility present later at the clinics (Maheshwari et al., 2008). Duration 
of infertility became one of the predictors to the success of infertility treatment apart 
from female age (Hakan E.Duran et al., 2002). But there are different views on 
whether duration of infertility successfully affecting the outcome of treatment.  Study 
done by Nuojua-Huttunen et al, 1999 found a significant decrease in pregnancy rate 
with an increasing duration of infertility, which was also similar to the finding of Tay 
et al. (2007). Finding from Krog et al. (2014) revealed different views of which 
duration of infertility has no predictive value towards the outcome of IVF. 
 
2.3  Sperm parameters 
 
Over the past 30 years, the World Health Organisation (WHO) has been 
attempting on the creation of reference threshold values for semen analysis as male 
infertility contributes towards 20-30% of infertility cases. This definition of male 
infertility is made either by diagnosis of a known cause of male infertility or based 
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solely on semen analyses in idiopathic cases (Murray et al., 2012). If interpreted 
correctly, the fast and inexpensive semen analysis remains the gold standard for 
defining a man’s role in subfertility (van der Steeg et al., 2011). Since 1987 the 
WHO has published five editions of the ‘‘WHO Manual for the Examination of 
Human Semen and Sperm–Cervical Mucus Interaction.’’  Prior to the development 
of WHO Manual in 2010, the reference values were based on the WHO manual 1999 
which has its own limitations (Cooper et al., 2010). 
The limitations were resulted from data that were derived from imprecisely 
defined reference populations and obtained from laboratories with unknown 
comparability with respect to analytical methodologies. These values were limited by 
the lack of available data on semen variables in recent fathers, and did not define true 
reference ranges or limits (Cooper et al., 2010). There are no true ‘‘fertile’’ or 
‘‘normal’’ cutoffs for semen parameters. The only way that quantitative parameter 
terminology can be used is to state a value as ‘‘above’’ or ‘‘below’’ minimum 
reference values (Murray et al., 2012). While some centres considered the cited 
values for characteristics of sperm concentration, morphology and mortality too high, 
whereas others considered them too low, the discrepancy can result in over- or 
under- diagnosis and hence leading to inappropriate management. It was hoped that 
the new development and application of clear reference ranges helps to reduce the 
incidence of misdiagnosis of fertility problem and improve clinical care.  
In the establishment of the new WHO guidelines on semen analysis, 
produced in 2010, semen samples from over 4500 men in 14 countries in 4 
continents were obtained from retrospective and prospective analyses on fertile men 
whose partners had a time-to-pregnancy (TTP) of ≤12 months, unscreened men of 
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unknown fertility status from general population (UNSCR), fertile men with no 
report of when they fathered children (NOTTP) and screened men of 
normozoospermic based on 1999 WHO standards (SCR). 
Men whose partners had a TTP ≤ 12 months were chosen as individuals to 
provide reference distributions for semen parameters since infertility is currently 
defined as a failure to conceive after at least 12 months of unprotected intercourse.  
TTP is a well-known and standardised epidemiological index , defined as the number 
of months (or cycles) from stopping contraception to achieving a pregnancy.  
Data on semen volume, sperm concentration, total sperm number per 
ejaculate , motility, vitality and normal morphology were included only if they were 
generated from complete semen samples, obtained following 2-7 days of sexual 
abstinence.  
The men in the reference population are characterised by not only larger 
semen volumes and higher concentrations and numbers of spermatozoa in their 
ejaculate, but also by a higher total number of motile and morphologically normal 
cells per ejaculate than found in the other groups.  
A comparison was made between WHO 1999 and WHO 2010  criteria, using 
529 consecutive semen samples from 427 men in order to determine how many men 
with normal screening according to WHO 1999 criteria would be considered having 
abnormal semen based on 2010 criteria and vice versa (Catanzariti et al., 2013). The 
study also aimed to determine which parameter of volume, concentration, motility 
and morphology is the most responsible of this change from normal (defined normal 
by all parameters) to abnormal (defined abnormal by at least one parameter) using 
the two WHO criteria. It was found out that  199 (37.83%) were considered normal 
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and 246 (46.76%) abnormal both according to WHO 1999 and WHO 2010 criteria; 3 
men were azoospermic and none of the samples previously classified as normal 
according to WHO 1999 criteria was considered abnormal after re-evaluation using 
WHO 2010 criteria. Meanwhile, 82 (15.58%) samples evaluated as abnormal 
according to 1999 criteria changed to normal according 2010 criteria. The 
concordance between 1999 and 2010 evaluation was 84.44%. The authors concluded 
that the changes from WHO 1999 to WHO 2010 criteria did not modify the 
interpretation of semen quality regardless whether all 3 parameters (count, motility 
and morphology) were considered or  not modify interpretation of semen quality, 
because comparing the two classifications it was demonstrated that there is a 
substantial agreement, among the three parameters (count, motility and morphology) 
all together, and also considering each single parameter. Despite that, almost 16% of 
the patients considered infertile according to the old criteria, should be evaluated 
normal by the new classification and they should not need any treatment for 
infertility. 
 
2.4	 	Menarche	
 
There are few data available investigating on the relationship of age at 
menarche and the subsequent fertility. The first menstrual bleeding, menarche, is the 
best recorded female pubertal milestone defining the beginning of ovulation and 
fecundity (Guldbrandsen et al., 2014). Girls, who do not have menarche by the age of 
16 years, are diagnosed as having delayed menarche. This condition indicates 
disturbance of the process of maturation of sexual functioning, and so might affect 
subsequent fertility. 
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A study done by Komura et al. (1992) was the first study investigating on the 
relationship between the age at menarche and subsequent reproductive functioning. 
The study was designed as a retrospective survey on 2281 healthy married women 
who received a medical check-up at the Health Test System between February 1986 
and January 1987. The women were each asked on their age at menarche, history of 
pregnancy and delivery; and whether their menstruations during the first few years 
after menarche had been regular. For the purpose of analysis, women who had 
disorders that prevent pregnancy, such as chromosomal abnormality or dysgenesis of 
the Miillerian duct (which are included in primary amenorrhea), those who had 
undergone hysterectomy before having a child, those who prevented conception and 
women who failed to conceive due to male infertility were excluded. Of the total 
2278 women surveyed, 115 (5.0%) were infertile. The age at menarche of the fertile 
group was 13.7 ± 0.1, which was significantly (P < 0.01) earlier than that of the 
infertile group (14.0 ± 0.2). The relationship of infertility with menstrual regularities 
in the first few years after menarche was investigated. A total of 2042 females (90%) 
had regular menstruations, and their rate of infertility was 4.7%. In contrast, among 
the women with irregular menstruations 8.9% were infertile. Thus women who had 
irregular menstruations had a significantly (P < 0.01) higher incidence of infertility. 
This study showed that in women who had menarche at the age of 18 or later 
the incidence of infertility is significantly higher than that in those with menarche 
before the age of 18. Among the women who had menarche before the age of 17, 
there was no relationship between the age at menarche and the rate of infertility. 
Therefore, women who had menarche at the age of 16 or 17, had normal 
reproductive functioning. This study also looked on the regularity of menses which 
showed that irregularity of menstruations during the first few years after menarche 
